241 related articles for article (PubMed ID: 32588978)
1. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study.
Fallico M; Avitabile T; Castellino N; Longo A; Russo A; Bonfiglio V; Parisi F; Furino C; Panozzo G; Scorcia V; Carnevali A; Bandello F; Parodi MB; Cennamo G; Cillino S; Vadalà M; Sunseri Trapani V; Cagini C; Fiore T; Lupidi M; Parravano M; Varano M; Giorno P; Boscia F; Giancipoli E; Eandi C; Le Mer Y; Reibaldi M
Acta Ophthalmol; 2021 Feb; 99(1):e74-e80. PubMed ID: 32588978
[TBL] [Abstract][Full Text] [Related]
2. DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification.
Furino C; Boscia F; Niro A; D'Addario M; Grassi MO; Saglimbene V; Reibaldi M; Alessio G
Retina; 2021 May; 41(5):1102-1109. PubMed ID: 32897932
[TBL] [Abstract][Full Text] [Related]
3. Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting.
Corbelli E; Fasce F; Iuliano L; Sacconi R; Lattanzio R; Bandello F; Querques G
Acta Diabetol; 2020 Oct; 57(10):1193-1201. PubMed ID: 32367246
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
5. COMPARISON OF INTRAVITREAL DEXAMETHASONE IMPLANT AND AFLIBERCEPT IN PATIENTS WITH TREATMENT-NAIVE DIABETIC MACULAR EDEMA WITH SEROUS RETINAL DETACHMENT.
Ozsaygili C; Duru N
Retina; 2020 Jun; 40(6):1044-1052. PubMed ID: 30950970
[TBL] [Abstract][Full Text] [Related]
6. Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
Danis RP; Sadda S; Li XY; Cui H; Hashad Y; Whitcup SM
Br J Ophthalmol; 2016 Jun; 100(6):796-801. PubMed ID: 26581718
[TBL] [Abstract][Full Text] [Related]
7. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
[TBL] [Abstract][Full Text] [Related]
8. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema.
Kaldırım H; Savur F; Kırgız A; Atalay K
Korean J Ophthalmol; 2020 Oct; 34(5):383-391. PubMed ID: 33099560
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
[TBL] [Abstract][Full Text] [Related]
11. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
Lo Giudice G; Avarello A; Campana G; Galan A
Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
[TBL] [Abstract][Full Text] [Related]
12. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
[TBL] [Abstract][Full Text] [Related]
13. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
Eandi CM; De Geronimo D; Giannini D; Polito MS; Tosi GM; Neri G; Le Mer Y; Varano M; Parravano M
Acta Diabetol; 2020 Jul; 57(7):867-874. PubMed ID: 32114643
[TBL] [Abstract][Full Text] [Related]
14. Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.
Chakraborty D; Mondal S; Sengupta S; Maiti A; Boral S; Das A; Sinha TK; Nandi K
Indian J Ophthalmol; 2024 Jul; 72(7):1001-1006. PubMed ID: 38622856
[TBL] [Abstract][Full Text] [Related]
15. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
Zur D; Iglicki M; Sala-Puigdollers A; Chhablani J; Lupidi M; Fraser-Bell S; Mendes TS; Chaikitmongkol V; Cebeci Z; Dollberg D; Busch C; Invernizzi A; Habot-Wilner Z; Loewenstein A;
Acta Ophthalmol; 2020 Mar; 98(2):e217-e223. PubMed ID: 31421028
[TBL] [Abstract][Full Text] [Related]
16. Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function.
Minnella AM; Maceroni M; Picardi SM; Placidi G; De Siena E; Rizzo S; Falsini B
Adv Ther; 2020 Nov; 37(11):4675-4684. PubMed ID: 32970316
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study.
Sarao V; Veritti D; Furino C; Giancipoli E; Alessio G; Boscia F; Lanzetta P
Acta Ophthalmol; 2017 Jun; 95(4):e255-e260. PubMed ID: 28139100
[TBL] [Abstract][Full Text] [Related]
20. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
